Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-005483
Filing Date
2014-02-06
Accepted
2014-02-06 16:18:27
Documents
1
Period of Report
2014-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd401506.html 4  
1 FORM 4 rrd401506.xml 4 3954
  Complete submission text file 0001181431-14-005483.txt   5288
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 39 YORKSHIRE DR OAKLAND CA 94618
Business Address
Novack David F (Reporting) CIK: 0001573072 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 14580368